176 related articles for article (PubMed ID: 22699436)
1. Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.
Prymula R; Pöllabauer EM; Pavlova BG; Löw-Baselli A; Fritsch S; Angermayr R; Geisberger A; Barrett PN; Ehrlich HJ
Hum Vaccin Immunother; 2012 Jun; 8(6):736-42. PubMed ID: 22699436
[TBL] [Abstract][Full Text] [Related]
2. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules.
Wittermann C; Schöndorf I; Gniel D
Vaccine; 2009 Mar; 27(10):1661-6. PubMed ID: 18940221
[TBL] [Abstract][Full Text] [Related]
3. Comparison of immunogenicity and safety between two paediatric TBE vaccines.
Pöllabauer EM; Pavlova BG; Löw-Baselli A; Fritsch S; Prymula R; Angermayr R; Draxler W; Firth C; Bosman J; Valenta B; Harmacek P; Maritsch F; Barrett PN; Ehrlich HJ
Vaccine; 2010 Jun; 28(29):4680-5. PubMed ID: 20433803
[TBL] [Abstract][Full Text] [Related]
4. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.
Loew-Baselli A; Konior R; Pavlova BG; Fritsch S; Poellabauer E; Maritsch F; Harmacek P; Krammer M; Barrett PN; Ehrlich HJ;
Vaccine; 2006 Jun; 24(24):5256-63. PubMed ID: 16624457
[TBL] [Abstract][Full Text] [Related]
6. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
[TBL] [Abstract][Full Text] [Related]
7. Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.
Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Koska M; Bobrovsky R; Konior R; Ehrlich HJ
Hum Vaccin; 2009 Aug; 5(8):551-6. PubMed ID: 19430202
[TBL] [Abstract][Full Text] [Related]
8. Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.
Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Firth C; Petermann R; Barrett PN; Ehrlich HJ
Vaccine; 2011 Oct; 29(43):7307-19. PubMed ID: 21843576
[TBL] [Abstract][Full Text] [Related]
9. Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity.
Ehrlich HJ; Pavlova BG; Fritsch S; Poellabauer EM; Loew-Baselli A; Obermann-Slupetzky O; Maritsch F; Cil I; Dorner F; Barrett PN
Vaccine; 2003 Dec; 22(2):217-23. PubMed ID: 14615149
[TBL] [Abstract][Full Text] [Related]
10. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
Wittermann C; Petri E; Zent O
Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
[TBL] [Abstract][Full Text] [Related]
11. Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines.
Beck Y; Fritz R; Orlinger K; Kiermayr S; Ilk R; Portsmouth D; Pöllabauer EM; Löw-Baselli A; Hessel A; Kölch D; Howard MK; Barrett PN; Kreil TR
J Virol; 2016 Feb; 90(4):1964-72. PubMed ID: 26656681
[TBL] [Abstract][Full Text] [Related]
12. Irregular tick-borne encephalitis vaccination schedules: the effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional study.
Schosser R; Reichert A; Mansmann U; Unger B; Heininger U; Kaiser R
Vaccine; 2014 Apr; 32(20):2375-81. PubMed ID: 24613521
[TBL] [Abstract][Full Text] [Related]
13. Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.
Konior R; Brzostek J; Poellabauer EM; Jiang Q; Harper L; Erber W
Vaccine; 2017 Jun; 35(28):3607-3613. PubMed ID: 28545923
[TBL] [Abstract][Full Text] [Related]
14. [Dynamics of antibody formation after vaccination against tick-borne encephalitis].
Pazdiora P; Januska J
Epidemiol Mikrobiol Imunol; 2004 Feb; 53(1):17-21. PubMed ID: 15052830
[TBL] [Abstract][Full Text] [Related]
15. Can the booster interval for the tick-borne encephalitis (TBE) vaccine 'FSME-IMMUN' be prolonged? - A systematic review.
Steffen R; Erber W; Schmitt HJ
Ticks Tick Borne Dis; 2021 Sep; 12(5):101779. PubMed ID: 34298356
[TBL] [Abstract][Full Text] [Related]
16. [Active immunization against tick-born encephalitis (TBE) among border guards (1993-2002)].
Knap J; Ryba S
Przegl Epidemiol; 2002; 56 Suppl 1():110-6. PubMed ID: 12194224
[TBL] [Abstract][Full Text] [Related]
17. Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults.
Poellabauer E; Angermayr R; Behre U; Zhang P; Harper L; Schmitt HJ; Erber W
Vaccine; 2019 May; 37(24):3241-3250. PubMed ID: 30928173
[TBL] [Abstract][Full Text] [Related]
18. [Determination of antibodies after immunization with the FSME-Immun vaccine].
Pazdiora P; Januska J; Kubátová A
Epidemiol Mikrobiol Imunol; 2000 Aug; 49(3):110-4. PubMed ID: 11040492
[TBL] [Abstract][Full Text] [Related]
19. Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21).
Schoendorf I; Ternak G; Oroszlàn G; Nicolay U; Banzhoff A; Zent O
Hum Vaccin; 2007; 3(2):42-7. PubMed ID: 17297298
[TBL] [Abstract][Full Text] [Related]
20. Immunological response in HIV-positive patients vaccinated against tick-borne encephalitis.
Panasiuk B; Prokopowicz D; Panasiuk A
Infection; 2003 Jan; 31(1):45-6. PubMed ID: 12590332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]